Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-845-579-5705

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

T: +1-347-918-3531

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Surgical Sphincteroplasty Market Outlook (2022-2032)

[250 Pages Report] According to Future Market Insight's newly released Surgical Sphincteroplasty Market analysis report, the market valuation stands at US$ 1.5 Bn in 2021 and is expected to rise at a CAGR of 7.4% during the forecasted period of 2022 to 2032. This can be seen as a significant fall from the historic CAGR of 6.1%.

The Global Market is expected to offer an absolute dollar opportunity of US$ 1.6 Bn during the forecasted period. The market is being driven by the increased prevalence of Anal Incontinence (AI), affordable sphincteroplasty procedures and the rising frequency of obstetric injury after childbirth.

Sphincteroplasty is the most common surgery performed for individuals with Anal Incontinence (Moderate to severe level), who have failed to respond to conservative treatment. As per the National Institute of Diabetes and Digestive and Kidney Diseases, Anal incontinence (AI) is a chronic illness affecting around 33% people globally.

Attributes Details
Surgical Sphincteroplasty Market CAGR (2022 to 2032) 7,4%
Surgical Sphincteroplasty Market Size (2022) US$ 1.6 Billion
Surgical Sphincteroplasty Market Size (2032) US$ 3.2 Billion

Furthermore, research show that AI affects roughly 15% of women in the general population and about 50% of those in nursing homes. The risk of Al is increased by additional factors like Pelvic surgery, age, recurrent diarrhoea, obesity, and other medical disorders such as diabetes and stroke.

Non-Surgical Sphincteroplasty stands to be the prominent segment in the Surgical Sphincteroplasty Market. It is likely to grow rapidly during the forecast period with the CAGR of 7.2%. This growth is significantly higher from the historical CAGR of 6.1%.

This rising percentage is due to the Non-Surgical category's increasing popularity among the elderly and its ability to promptly restore anal sphincter control after delivery. Sacral nerve stimulation, vaginal balloon implants, and other treatments are among the options. Non-surgical treatments have shown encouraging results in patients with end-stage AI and those who have failed to respond to traditional treatment.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Revenue Of Surgical Sphincteroplasty Market From 2017 To 2021 Compared To Demand Outlook For 2022 To 2032

As per the publications released by Future Market Insight - market research and competitive intelligence provider, the Surgical Sphincteroplasty Market is valued at US$ 1.5 Bn in 2021 and is expected to become a US$ 1.6 Bn market by the end of 2022.

The projected CAGR stands at 7.4% for the period between 2022 and 2032, which is significantly higher than the historical CAGR of just 6.1% due to an increase in Anal Incontinence (AI), affordable sphincteroplasty procedures and the rising frequency of obstetric injury after childbirth.

The market is estimated to offer an absolute dollar opportunity of US$ 1.6 Bn in the period between 2022 and 2032 and is likely to record a valuation of US$ 3.2 Bn by 2032.

The key developments in Market are:

  • The Surgical Sphincteroplasty Market was valued at US$ 1.5 Bn in 2021 and by the end of 2022 it is expected to touch the valuation of US$ 1.6 Bn.
  • The Global Market for Surgical Sphincteroplasty is estimated to provide an absolute dollar opportunity of US$ 1.6 Bn in the forecast period (2022-2032).
  • During 2017-2021, the Surgical Sphincteroplasty market was growing at a CAGR of 6.1%.
  • The market will be growing at a CAGR of 7.4% during the forecasted period (2022-2032) to reach the valuation of US$ 3.2 Bn by the end of 2032.
  • The report published by Future Market Insight states that the Global Surgical Sphincteroplasty market will grow 2X during the period between 2022 and 2032.
  • The Non-Surgical segment will be dominating the Global market and is expected to grow at a CAGR of 7.2% during the forecast period compared to the historical CAGR of 6.1%.
  • North America is likely to dominate the Global Market for Surgical Sphincteroplasty and is likely to grow at a CAGR of 7.2% during the forecast period.

What Factors Are Driving The Growth Of The Global Surgical Sphincteroplasty Market?

In comparison to other therapies for incontinence, sphincteroplasty is a feasible procedure and has become more popular among surgeons. The procedure with low-maintenance and a high success rate is likely to push the adoption rate in healthcare segment.

The rising prevalence of anal incontinence, obstetric damage after childbirth, the increasing innovative approaches for treating AI and the expanding number of clinical studies are all driving the industry forward.

Presented medical conditions ranging from adult in tow to obesity may lead to the increase of the risk of anal incontinence to as high as ninety percent. Thus, increasing the demand for Surgical Sphincteroplasty procedures for treating such medical ailments.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What Was The Impact Of The Covid-19 Pandemic On The Global Surgical Sphincteroplasty Market?

The worldwide economy was severely hit by the COVID-19 pandemic. The COVID-19 pandemic emerged abruptly and prompted the imposition of strict lockdown measures in several countries. Clinical trials in industrialised countries were terminated as a result of pandemic, thus affecting the market growth.

Furthermore, the fear of contacting virus from hospitals visits resulted in fewer elective procedures and lower hospital admission rates. The surgical sphincteroplasty market has been hit by a shortage of surgical supplies as a result of a logistical problems as well as a shortage of hospital care workers. However, it is expected to become competitive by the end of 2022 with patients returning to hospitals with their delayed elective and interventional surgeries.

Country-Wise Analysis

Which Country is the Driving Force behind the growth of the Global Surgical Sphincteroplasty Market?

The United States is the driving force behind the growth of Global Surgical Sphincteroplasty Market. It is expected to remain a dominant market player in the Global Market with the market share of over 35%. The U.S. Market is expected to grow exponentially at a CAGR of 7.2% during the forecasted period, while its historical growth stands at just 6.1%.

Between 2022 and 2032, the market is estimated to offer an absolute dollar opportunity of US$ 568.7 Mn. The region is likely to remain dominant market player due to better healthcare infrastructure and the presence of major industry players. Besides, the market is expected to develop because of an increased R&D expenditure for establishment of concrete treatment choices for anal incontinence.

Which country is expected to grow rapidly in the Global Surgical Sphincteroplasty Market?

According to Future Market Insight data, the market in Japan is anticipated to grow at the fastest rate of 11.1% during the period between 2022 and 2032. Its compound annual growth rate is much higher than the historical rate of just 5.3%. In the next ten years, the Japanese market for Surgical Sphincteroplasty is estimated to offer an absolute dollar opportunity of US$ 83.3 million.

The market growth is attributable to the factors such as rising geriatric population, improved adoption rate, greater prevalence of cost-effective operations like sphincteroplasty, improving healthcare infrastructure and higher government investment in the healthcare sector.

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-Wise Insights

Which product category is gaining the utmost traction among the various products discussed in the study?

The Non-Surgical segment is gaining the utmost traction and was the highest revenue generating segment in the Global Surgical Sphincteroplasty Market. It is expected to grow at a CAGR of 7.2% during the forecasted period. The forecasted growth is significantly higher than the historical growth of just 6.1% during the period between 2017 and 2021.

This is due to its rising popularity among the elderly and its ability to promptly restore anal sphincter control after administration. Sacral nerve stimulation, vaginal balloon implants, and other treatments are included in this category.

Non-surgical treatments have shown encouraging results in patients with end-stage AI and those who have failed to respond to traditional treatment. Due to its high success rate and the ability to reverse or terminate treatment without permanently harming the sacral nerves, sacral nerve stimulation received the most votes.

Competitive Analysis

The leading players in the Surgical Sphincteroplasty Market are increasing their R&D spending to fund the development of strategically advanced offerings. Furthermore, government funding, technological advancements, regulatory approvals, mergers and acquisitions and building a diverse product portfolio have all contributed to the competitive environment's health.

In the market for surgical sphincteroplasty, an increase in clinical advances to produce innovative products is offering attractive opportunities.

It is stated to be a low competitive market because there are fewer market competitors offering surgical solutions to treat anal incontinence. Larger market players, on the other hand, are reported to be boosting market growth through development tactics such as partnership and acquisition.

The key competitors in the Surgical Sphincteroplasty Market are Medtronic, Hill-Rom Services, Inc., McKesson, B. Braun, Becton, Dickinson and Company, Novo Surgical, Inc., Surgical Holdings, Pelvalon, Salix Pharmaceutical Inc., Johnson & Johnson, etc.

The recent developments in the Global Surgical Sphincteroplasty Market which were being channelised by market players are as follows:

  • In December 2021, The Baxter International Inc. completes the acquisition Hillrom for a price of US$ 12.5 billion to accelerate its vision of transforming the healthcare sector from hospitals to home.
  • In November 2021, Walgreens Boots Alliance acquired a 30% stake in McKesson's German GEHE-Alliance Healthcare Joint Venture. This will ultimately lead to Walgreens Boots Alliance taking control of 100% of the venture, which McKesson originally obtained.
  • In December 2021, Tissuemed Ltd. was acquired by Becton, Dickinson and Company to make further advancements in its existing product portfolio. It will combine BD's experience with Tissuemed's solid base to establish itself as a dominant player across the globe.

Similarly, recent developments related to companies offering Surgical Sphincteroplasty have been tracked by the team at Future Market Insight, which are available in the full report.

Surgical Sphincteroplasty Market Report Scope

Attribute Details
Forecast Period 2022 to 2032
Historical Data 2017 to 2021
Quantitative Units In US$ Billion
Key Regions Covered North America, Latin America, Europe, APAC and MEA
Key Countries Covered United States, China, Japan, South Korea, UK., Canada, Brazil, Mexico, Germany, France, Spain, Italy, Russia, India, Australia, South Africa, Saudi Arabia, UAE, Israel
Key Market Segments Covered Type and Region
Key Companies Profiled
  • Medtronic
  • Hill-Rom Services, Inc.
  • McKesson
  • B. Braun
  • Becton, Dickinson and Company
  • Novo Surgical, Inc.
  • Surgical Holdings
  • Pelvalon
  • Salix Pharmaceutical Inc.
  • Johnson & Johnson
Pricing Available upon Request

Market Segments Covered In Surgical Sphincteroplasty Market Analysis

By Type:

  • Surgical
    • Direct apposition sphincteroplasty
    • Overlapping sphincteroplasty
  • Non-Surgical
    • Sacral nerve stimulation
    • Vaginal balloon inserts
    • Other Non-Surgical

By Region type:

  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Europe
    • Germany
    • U.K.
    • France
    • Spain
    • Italy
    • Russia
    • Others
  • APAC
    • India
    • China
    • Japan
    • South Korea
    • Australia
    • Others
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others

Frequently Asked Questions

What is the current valuation of the Global Surgical Sphincteroplasty Devices Market?

In 2021, the Global Surgical Sphincteroplasty Devices Market is worth US$ 1.5 Bn and is expected to reach US$ 1.6 Bn by the end of 2022.

What is the future of the Global Surgical Sphincteroplasty Market?

The Global Surgical Sphincteroplasty Market is expected to grow at a CAGR of 7.4% during the forecasted period of 2022 to 2032.

What will be the valuation of Global Surgical Sphincteroplasty Market at the end of 2032?

The Global Surgical Sphincteroplasty Market is expected to be valued at US$ 3.2 bn by the end of 2032 by growing at a CAGR of 7.4% during next 10 years.

What is the absolute dollar opportunity of the Global Surgical Sphincteroplasty Market?

The Global Surgical Sphincteroplasty Market is expected to provide an absolute dollar opportunity of US$ 1.6 Bn during the period 2022 - 2032.

Which are the key players in the Global Surgical Sphincteroplasty Market?

The key players operating in the Global Surgical Sphincteroplasty Market are Medtronic, Hill-Rom Services, Inc., McKesson, B. Braun, Becton, Dickinson and Company, Novo Surgical, Inc., Surgical Holdings, Pelvalon, Salix Pharmaceutical Inc., and Johnson & Johnson.

Which region is the driving force behind the growth of the Global Surgical Sphincteroplasty Market?

The U.S. dominates the Global Surgical Sphincteroplasty Market with a majority share of over 35% during the current period. The U.S. market is expected to grow at a CAGR of 7.2% during the forecast period, owing to the growing presence of global market players, rising R&D expenditure and favorable regulatory developments in the region.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Investment Feasibility Matrix

    3.6. PESTLE and Porter’s Analysis

    3.7. Regulatory Landscape

        3.7.1. By Key Regions

        3.7.2. By Key Countries

    3.8. Regional Parent Market Outlook

4. Global Market Analysis 2017-2021 and Forecast, 2022-2032

    4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

    4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Mn) Analysis By Type, 2017-2021

    5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Type, 2022-2032

        5.3.1. Surgical Sphincetroplasty

        5.3.2. Non-Surgical Sphincetroplasty

    5.4. Y-o-Y Growth Trend Analysis By Type, 2017-2021

    5.5. Absolute $ Opportunity Analysis By Type, 2022-2032

6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region

    6.1. Introduction

    6.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

    6.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

        6.3.1. North America

        6.3.2. Latin America

        6.3.3. Europe

        6.3.4. Asia Pacific

        6.3.5. Middle East and Africa

    6.4. Market Attractiveness Analysis By Region

7. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    7.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    7.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        7.2.1. By Country

            7.2.1.1. U.S.

            7.2.1.2. Canada

        7.2.2. By Type

    7.3. Market Attractiveness Analysis

        7.3.1. By Country

        7.3.2. By Type

    7.4. Key Takeaways

8. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        8.2.1. By Country

            8.2.1.1. Brazil

            8.2.1.2. Mexico

            8.2.1.3. Rest of Latin America

        8.2.2. By Type

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Type

    8.4. Key Takeaways

9. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        9.2.1. By Country

            9.2.1.1. Germany

            9.2.1.2. U.K.

            9.2.1.3. France

            9.2.1.4. Spain

            9.2.1.5. Italy

            9.2.1.6. Russia

            9.2.1.7. Rest of Europe

        9.2.2. By Type

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Type

    9.4. Key Takeaways

10. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        10.2.1. By Country

            10.2.1.1. China

            10.2.1.2. Japan

            10.2.1.3. India

            10.2.1.4. South Korea

            10.2.1.5. Australia

            10.2.1.6. Rest of APAC

        10.2.2. By Type

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Type

    10.4. Key Takeaways

11. Middle East and Africa Market Analysis 2017-2021 and Forecast 2022-2032, By Country

    11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

    11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

        11.2.1. By Country

            11.2.1.1. South Africa

            11.2.1.2. Saudi Arabia

            11.2.1.3. UAE

            11.2.1.4. Israel

            11.2.1.5. Rest of MEA

        11.2.2. By Type

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Type

    11.4. Key Takeaways

12. Key Countries Market Analysis

    12.1. U.S.

        12.1.1. Pricing Analysis

        12.1.2. Market Share Analysis, 2021

            12.1.2.1. By Type

    12.2. Canada

        12.2.1. Pricing Analysis

        12.2.2. Market Share Analysis, 2021

            12.2.2.1. By Type

    12.3. Brazil

        12.3.1. Pricing Analysis

        12.3.2. Market Share Analysis, 2021

            12.3.2.1. By Type

    12.4. Mexico

        12.4.1. Pricing Analysis

        12.4.2. Market Share Analysis, 2021

            12.4.2.1. By Type

    12.5. Germany

        12.5.1. Pricing Analysis

        12.5.2. Market Share Analysis, 2021

            12.5.2.1. By Type

    12.6. U.K.

        12.6.1. Pricing Analysis

        12.6.2. Market Share Analysis, 2021

            12.6.2.1. By Type

    12.7. France

        12.7.1. Pricing Analysis

        12.7.2. Market Share Analysis, 2021

            12.7.2.1. By Type

    12.8. Spain

        12.8.1. Pricing Analysis

        12.8.2. Market Share Analysis, 2021

            12.8.2.1. By Type

    12.9. Italy

        12.9.1. Pricing Analysis

        12.9.2. Market Share Analysis, 2021

            12.9.2.1. By Type

    12.10. Russia

        12.10.1. Pricing Analysis

        12.10.2. Market Share Analysis, 2021

            12.10.2.1. By Type

    12.11. China

        12.11.1. Pricing Analysis

        12.11.2. Market Share Analysis, 2021

            12.11.2.1. By Type

    12.12. Japan

        12.12.1. Pricing Analysis

        12.12.2. Market Share Analysis, 2021

            12.12.2.1. By Type

    12.13. India

        12.13.1. Pricing Analysis

        12.13.2. Market Share Analysis, 2021

            12.13.2.1. By Type

    12.14. South Korea

        12.14.1. Pricing Analysis

        12.14.2. Market Share Analysis, 2021

            12.14.2.1. By Type

    12.15. Australia

        12.15.1. Pricing Analysis

        12.15.2. Market Share Analysis, 2021

            12.15.2.1. By Type

    12.16. South Africa

        12.16.1. Pricing Analysis

        12.16.2. Market Share Analysis, 2021

            12.16.2.1. By Type

    12.17. Saudi Arabia

        12.17.1. Pricing Analysis

        12.17.2. Market Share Analysis, 2021

            12.17.2.1. By Type

    12.18. UAE

        12.18.1. Pricing Analysis

        12.18.2. Market Share Analysis, 2021

            12.18.2.1. By Type

    12.19. Israel

        12.19.1. Pricing Analysis

        12.19.2. Market Share Analysis, 2021

            12.19.2.1. By Type

13. Market Structure Analysis

    13.1. Competition Dashboard

    13.2. Competition Benchmarking

    13.3. Market Share Analysis of Top Players

        13.3.1. By Regional

        13.3.2. By Type

14. Competition Analysis

    14.1. Competition Deep Dive

        14.1.1. Medtronic

            14.1.1.1. Overview

            14.1.1.2. Product Portfolio

            14.1.1.3. Profitability by Market Segments

            14.1.1.4. Sales Footprint

            14.1.1.5. Strategy Overview

                14.1.1.5.1. Marketing Strategy

        14.1.2. Hill-Rom Services, Inc.

            14.1.2.1. Overview

            14.1.2.2. Product Portfolio

            14.1.2.3. Profitability by Market Segments

            14.1.2.4. Sales Footprint

            14.1.2.5. Strategy Overview

                14.1.2.5.1. Marketing Strategy

        14.1.3. McKesson

            14.1.3.1. Overview

            14.1.3.2. Product Portfolio

            14.1.3.3. Profitability by Market Segments

            14.1.3.4. Sales Footprint

            14.1.3.5. Strategy Overview

                14.1.3.5.1. Marketing Strategy

        14.1.4. B. Braun

            14.1.4.1. Overview

            14.1.4.2. Product Portfolio

            14.1.4.3. Profitability by Market Segments

            14.1.4.4. Sales Footprint

            14.1.4.5. Strategy Overview

                14.1.4.5.1. Marketing Strategy

        14.1.5. Becton, Dickinson and Company

            14.1.5.1. Overview

            14.1.5.2. Product Portfolio

            14.1.5.3. Profitability by Market Segments

            14.1.5.4. Sales Footprint

            14.1.5.5. Strategy Overview

                14.1.5.5.1. Marketing Strategy

        14.1.6. Novo Surgical, Inc.

            14.1.6.1. Overview

            14.1.6.2. Product Portfolio

            14.1.6.3. Profitability by Market Segments

            14.1.6.4. Sales Footprint

            14.1.6.5. Strategy Overview

                14.1.6.5.1. Marketing Strategy

        14.1.7. Surgical Holdings

            14.1.7.1. Overview

            14.1.7.2. Product Portfolio

            14.1.7.3. Profitability by Market Segments

            14.1.7.4. Sales Footprint

            14.1.7.5. Strategy Overview

                14.1.7.5.1. Marketing Strategy

        14.1.8. Pelvalon

            14.1.8.1. Overview

            14.1.8.2. Product Portfolio

            14.1.8.3. Profitability by Market Segments

            14.1.8.4. Sales Footprint

            14.1.8.5. Strategy Overview

                14.1.8.5.1. Marketing Strategy

        14.1.9. Salix Pharmaceutical Inc.

            14.1.9.1. Overview

            14.1.9.2. Product Portfolio

            14.1.9.3. Profitability by Market Segments

            14.1.9.4. Sales Footprint

            14.1.9.5. Strategy Overview

                14.1.9.5.1. Marketing Strategy

        14.1.10. Johnson & Johnson

            14.1.10.1. Overview

            14.1.10.2. Product Portfolio

            14.1.10.3. Profitability by Market Segments

            14.1.10.4. Sales Footprint

            14.1.10.5. Strategy Overview

                14.1.10.5.1. Marketing Strategy

15. Assumptions & Acronyms Used

16. Research Methodology

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

List of Tables

Table 01: Global Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 02: Global Market Value (US$ Mn) Forecast by Type, 2017-2032

Table 03: North America Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 04: North America Market Value (US$ Mn) Forecast by Type, 2017-2032

Table 05: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 06: Latin America Market Value (US$ Mn) Forecast by Type, 2017-2032

Table 07: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 08: Europe Market Value (US$ Mn) Forecast by Type, 2017-2032

Table 09: Asia Pacific Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 10: Asia Pacific Market Value (US$ Mn) Forecast by Type, 2017-2032

Table 11: Middle East and Africa Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 12: Middle East and Africa Market Value (US$ Mn) Forecast by Type, 2017-2032
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 01: Global Market Value (US$ Mn) by Type, 2022-2032

Figure 02: Global Market Value (US$ Mn) by Region, 2022-2032

Figure 03: Global Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 04: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 05: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 06: Global Market Value (US$ Mn) Analysis by Type, 2017-2032

Figure 07: Global Market Value Share (%) and BPS Analysis by Type, 2022-2032

Figure 08: Global Market Y-o-Y Growth (%) Projections by Type, 2022-2032

Figure 09: Global Market Attractiveness by Type, 2022-2032

Figure 10: Global Market Attractiveness by Region, 2022-2032

Figure 11: North America Market Value (US$ Mn) by Type, 2022-2032

Figure 12: North America Market Value (US$ Mn) by Country, 2022-2032

Figure 13: North America Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 14: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 15: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 16: North America Market Value (US$ Mn) Analysis by Type, 2017-2032

Figure 17: North America Market Value Share (%) and BPS Analysis by Type, 2022-2032

Figure 18: North America Market Y-o-Y Growth (%) Projections by Type, 2022-2032

Figure 19: North America Market Attractiveness by Type, 2022-2032

Figure 20: North America Market Attractiveness by Country, 2022-2032

Figure 21: Latin America Market Value (US$ Mn) by Type, 2022-2032

Figure 22: Latin America Market Value (US$ Mn) by Country, 2022-2032

Figure 23: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 24: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 25: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 26: Latin America Market Value (US$ Mn) Analysis by Type, 2017-2032

Figure 27: Latin America Market Value Share (%) and BPS Analysis by Type, 2022-2032

Figure 28: Latin America Market Y-o-Y Growth (%) Projections by Type, 2022-2032

Figure 29: Latin America Market Attractiveness by Type, 2022-2032

Figure 30: Latin America Market Attractiveness by Country, 2022-2032

Figure 31: Europe Market Value (US$ Mn) by Type, 2022-2032

Figure 32: Europe Market Value (US$ Mn) by Country, 2022-2032

Figure 33: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 34: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 35: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 36: Europe Market Value (US$ Mn) Analysis by Type, 2017-2032

Figure 37: Europe Market Value Share (%) and BPS Analysis by Type, 2022-2032

Figure 38: Europe Market Y-o-Y Growth (%) Projections by Type, 2022-2032

Figure 39: Europe Market Attractiveness by Type, 2022-2032

Figure 40: Europe Market Attractiveness by Country, 2022-2032

Figure 41: Asia Pacific Market Value (US$ Mn) by Type, 2022-2032

Figure 42: Asia Pacific Market Value (US$ Mn) by Country, 2022-2032

Figure 43: Asia Pacific Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 44: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 45: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 46: Asia Pacific Market Value (US$ Mn) Analysis by Type, 2017-2032

Figure 47: Asia Pacific Market Value Share (%) and BPS Analysis by Type, 2022-2032

Figure 48: Asia Pacific Market Y-o-Y Growth (%) Projections by Type, 2022-2032

Figure 49: Asia Pacific Market Attractiveness by Type, 2022-2032

Figure 50: Asia Pacific Market Attractiveness by Country, 2022-2032

Figure 51: Middle East and Africa Market Value (US$ Mn) by Type, 2022-2032

Figure 52: Middle East and Africa Market Value (US$ Mn) by Country, 2022-2032

Figure 53: Middle East and Africa Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 54: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 55: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 56: Middle East and Africa Market Value (US$ Mn) Analysis by Type, 2017-2032

Figure 57: Middle East and Africa Market Value Share (%) and BPS Analysis by Type, 2022-2032

Figure 58: Middle East and Africa Market Y-o-Y Growth (%) Projections by Type, 2022-2032

Figure 59: Middle East and Africa Market Attractiveness by Type, 2022-2032

Figure 60: Middle East and Africa Market Attractiveness by Country, 2022-2032

Recommendations

Healthcare

Non-invasive Surgical Wound Closure Market

Published : October 2022

Explore Healthcare Insights

View Reports

Surgical Sphincteroplasty Market